These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1830 related articles for article (PubMed ID: 18243010)

  • 21. Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
    Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC
    BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
    J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.
    Jatoi A; Hillman S; Stella P; Green E; Adjei A; Nair S; Perez E; Amin B; Schild SE; Castillo R; Jett JR;
    J Clin Oncol; 2005 Dec; 23(36):9113-9. PubMed ID: 16361618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
    Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
    Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
    Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos HP; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
    Anticancer Res; 2006; 26(4B):3175-81. PubMed ID: 16886653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
    Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet.
    Comella P; Casaretti R; Manzo R; Sandomenico C; Licenziato M; Avallone A; Franco L;
    Acta Oncol; 2010; 49(1):50-6. PubMed ID: 20100144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
    Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
    J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
    Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
    Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predicting outcome for advanced gastroesophageal cancer in elderly patients receiving palliative chemotherapy.
    Lord SR; Hall PS; McShane P; Brown J; Seymour MT
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):107-13. PubMed ID: 20053542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
    Orlando L; Cardillo A; Rocca A; Balduzzi A; Ghisini R; Peruzzotti G; Goldhirsch A; D'Alessandro C; Cinieri S; Preda L; Colleoni M
    Anticancer Drugs; 2006 Sep; 17(8):961-7. PubMed ID: 16940806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
    Aparicio T; Navazesh A; Boutron I; Bouarioua N; Chosidow D; Mion M; Choudat L; Sobhani I; Mentré F; Soulé JC
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):249-57. PubMed ID: 19131256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer.
    Oh Y; Herbst RS; Burris H; Cleverly A; Musib L; Lahn M; Bepler G
    J Clin Oncol; 2008 Mar; 26(7):1135-41. PubMed ID: 18309949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC
    Cancer; 2007 Jan; 109(2):274-81. PubMed ID: 17154161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How should we treat elderly patients with small cell lung cancer?--information gathered by questionnaires and analysis of 351 patients aged 70 or over. West Japan Thoracic Oncology Group].
    Gan To Kagaku Ryoho; 1999 May; 26(6):797-804. PubMed ID: 10410149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of radiotherapy for liver metastases].
    Eble MJ; Gademann G; Wannenmacher M
    Strahlenther Onkol; 1993 Aug; 169(8):459-68. PubMed ID: 7689254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
    Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
    Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.
    Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Zauderer M; Howard J; Hudis C
    Breast Cancer Res Treat; 2005 Jul; 92(2):151-6. PubMed ID: 15986124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.